Weight-loss drugs reshape food demand; manufacturers face product reformulation pressure

Food manufacturers are confronting a structural shift in consumer demand as GLP-1 weight-loss medications reduce cravings for unhealthy foods, not just hunger. This could force product portfolio changes and affect sales of processed foods. The extent of impact varies by demographic and remains uncertain, but the trend is gaining recognition in the industry.